Iovance Biotherapeutics (IOVA)
(Delayed Data from NSDQ)
$11.87 USD
+0.25 (2.15%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $11.82 -0.05 (-0.42%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | -0.33 |
EPS Last Quarter | -0.34 |
Last EPS Surprise | 8.11% |
ABR | 1.29 |
Earnings ESP
|
7.27% |
---|---|
Current Year | -1.26 |
Next Year | -0.80 |
EPS (TTM) | -1.67 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 53.54M | 76.97M | 161.68M | 453.50M |
# of Estimates | 5 | 6 | 6 | 6 |
High Estimate | 54.21M | 80.00M | 164.30M | 474.00M |
Low Estimate | 53.00M | 74.75M | 158.93M | 437.83M |
Year ago Sales | 0.47M | 0.48M | 1.19M | 161.68M |
Year over Year Growth Est. | 11,290.64% | 15,936.04% | 13,497.81% | 180.49% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.33 | -0.33 | -1.26 | -0.80 |
# of Estimates | 7 | 6 | 8 | 7 |
Most Recent Consensus | -0.45 | -0.47 | -1.01 | -0.86 |
High Estimate | -0.25 | -0.19 | -0.84 | -0.45 |
Low Estimate | -0.45 | -0.47 | -1.52 | -1.17 |
Year ago EPS | -0.46 | -0.45 | -1.89 | -1.26 |
Year over Year Growth Est. | 28.26% | 26.67% | 33.33% | 37.05% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 4 | 3 |
Up Last 60 Days | 1 | 1 | 4 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 3 | 3 | 3 | 3 |
Down Last 60 Days | 3 | 3 | 3 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.33 | -0.33 | -1.26 | -0.80 |
7 Days Ago | -0.33 | -0.33 | -1.26 | -0.80 |
30 Days Ago | -0.31 | -0.26 | -1.35 | -0.86 |
60 Days Ago | -0.31 | -0.26 | -1.34 | -0.84 |
90 Days Ago | -0.31 | -0.27 | -1.36 | -0.94 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.31 | -0.31 | -1.24 | -0.78 |
Zacks Consensus Estimate | -0.33 | -0.33 | -1.26 | -0.80 |
Earnings ESP | 7.27% | 6.53% | 1.67% | 1.56% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.34 | -0.42 | -0.45 | -0.46 | NA |
Estimate | -0.37 | -0.45 | -0.44 | -0.46 | NA |
Difference | 0.03 | 0.03 | -0.01 | 0.00 | 0.01 |
Surprise | 8.11% | 6.67% | -2.27% | 0.00% | 3.13% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more